STI571 Type of group
Sponsors
NOVARTIS BIOSCIENSES PERU S.A.,
Unknown Phase
AN OPEN STUDY TO DETERMINE THE EFFICACY AND SAFETY OF STI571 IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN BLASTICA CRISIS
Active, not recruitingPER-074-00
Updated: 2023-09-04
A STUDY TO DETERMINE THE EFFICACY AND SAFETY OF STI571 IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN ACCELERATED PHASE
Active, not recruitingPER-073-00
Updated: 2023-09-04
A STUDY TO DETERMINE THE SAFETY AND EFFICACY OF STI571 IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA THAT ARE HEMATOLOGICALLY OR CYGOGENICALLY RESISTANT OR REFRACTORY OR INTOLERANT TO THE ALPHA INTERFERON
Active, not recruitingPER-004-01
Updated: 2023-09-04